We present our project in the DemoDay in La Salle Technova, where Ship2B impulse with big corporates.
Finalists in the Investment Forum from ACCIÓ 2018!
We have assisted to the IE Venture Network Area 31 in Madrid.
ADmit Therapeutics selected in the MedTeX programme organized by Barcelona Scientific Park.
The new EU IVD Regulation has finally been adopted on April 5th 2017 and ADmit Therapeutics has already drawn the development plan according to this new Regulation.
ADmit Therapeutics has been created, acquiring a license agreement with IDIBELL and University of Barcelona to develop a test for an early AD detection.